Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02927197 · ClinicalTrials.gov registry record · NA
LearningRx Brain Training for Children 8-14
A NA study, sponsored by Gibson Institute of Cognitive Research.
- Completed
- Registry status
- NA
- Development phase
- 39
- Enrollment target
NCT02927197: Completed NA study, sponsored by Gibson Institute of Cognitive Research.
NCT02927197 is a NA study that has completed, run by Gibson Institute of Cognitive Research. The registered enrollment target is 39 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02927197, a NA study, has completed, sponsored by Gibson Institute of Cognitive Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 39 participants
- Enrollment target
Study Summary
The purpose of this study is to examine changes in multiple cognitive skills after completing 60 hours of cognitive training with ThinkRx, a LearningRx program.
Primary Outcome
Confirmed by pretest to post-test change on the Woodcock Johnson III - Tests of Cognitive Abilities (WJ III): General Intellectual Ability composite score
Interventions
- BEHAVIORAL LearningRx cognitive training
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 39 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-06 |
| Phase | NA |
What the finished NCT02927197 record still lists
NCT02927197 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 39 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (97% lower).
The record links to 0 conditions, and to 1 intervention - of which LearningRx cognitive training is the first listed.
NCT02927197 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02927197 about?
NCT02927197 is a clinical study titled "LearningRx Brain Training for Children 8-14". The purpose of this study is to examine changes in multiple cognitive skills after completing 60 hours of cognitive training with ThinkRx, a LearningRx program.
What is the current status of trial NCT02927197?
This trial is currently completed. It is a NA study. The enrollment target is 39 participants. The study started on 2015-06. Estimated completion is 2017-06.
What interventions are being tested in trial NCT02927197?
The interventions under investigation include: LearningRx cognitive training (BEHAVIORAL).
Who is sponsoring clinical trial NCT02927197?
This trial is sponsored by Gibson Institute of Cognitive Research, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT02927197's enrollment target sits among peer trials
39 1536th of 2000 higher than 463 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03465592 · 39 participants · Phase 1
Trial of Nivolumab Following Partially Human Leukocyte Antigen (HLA) Mismatched BMT in Children & Adults With Sarcoma
- NCT03961776 · 39 participants
Monitoring Treatment Response With On-board DWI During Neo-adjuvant Chemo-radiation for Rectal Cancer Using Magnetic Resonance-guided-radiotherapy Systems
- NCT04050280 · 39 participants · Phase 2
CLAG-GO for Patients With Persistent, Relapsed or Refractory AML
- NCT04190862 · 39 participants · Phase 1
E-CEL UVEC as an Adjunct Cell Therapy for Treatment of Anal Fistulas
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia